Financhill
Back

PTC Therapeutics Quote, Financials, Valuation and Earnings

Buy
53

PTCT
PTC Therapeutics

Last Price:
35.80
Seasonality Move:
15.47%

7 Day Trial

ALL ACCESS PASS

$ 7

PTC Therapeutics Price Quote

$35.80
-0.01 (-2.95%)
(Updated: June 15, 2024 at 5:39 AM ET)

PTC Therapeutics Key Stats

Buy
53
PTC Therapeutics (PTCT) is a Buy

Day range:
$35.53 - $36.57
52-week range:
$17.53 - $44.66
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.92
P/B ratio:
0%

Volume:
837.7K
Avg. volume:
833.6K
1-year change:
-16.74%
Market cap:
$2.7B
Revenue:
$937.8M
EPS:
$-7.68

How Much Does PTC Therapeutics Make?

Is PTC Therapeutics Growing As A Company?

  • What Is PTC Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.05%
  • What Is PTC Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

PTC Therapeutics Stock Price Performance

  • Did PTC Therapeutics Stock Go Up Last Month?
    PTC Therapeutics share price went up by 14.85% last month
  • Did PTCT's Share Price Rise Over The Last Year?
    PTCT share price fell by -16.74% over the past 1 year

What Is PTC Therapeutics 52-Week High & Low?

PTC Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PTC Therapeutics?

  • How Much Debt Does PTC Therapeutics Have?
    Total long term debt quarterly is $284.5M
  • How Much Cash Does PTC Therapeutics Have?
    Cash and short term investments quarterly total is $884.8M
  • What Is PTC Therapeutics’s Book Value Per Share?
    Book value per share is -11.66

Is PTC Therapeutics Cash Flow Positive?

  • What Is PTCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.2M
  • What Is PTC Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $642.8M
  • What Is PTC Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$262.7M

PTC Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PTCT return on invested capital is -425.51%
  • What Is PTC Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -36.7%
  • What Is PTCT Return On Equity?
    ROE is a measure of profitability and is 0%

PTC Therapeutics Earnings Date & Stock Price

PTC Therapeutics Competitors

  • Who Are PTC Therapeutics's Competitors?
    Below is a list of companies who compete with PTC Therapeutics or are related in some way:
    • Biogen Inc (BIIB)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Oragenics Inc (OGEN)
    • Pfizer Inc (PFE)
    • Sarepta Therapeutics Inc (SRPT)

PTC Therapeutics Dividend Yield

Data Unavailable

PTC Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -9.09%
Revenue: -4.66% 28.26%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 4
Sell Recommendations: 1
Price Target: 36.73
Upside from Last Price: 2.56%

Major Shareholders

  • How many PTCT shares are owned by institutional investors?
    138.4M PTCT shares are owned by institutional investors
  • How many PTCT shares are owned by insiders?
    1.3M PTCT shares are owned by insiders